Caterina Casari/ISTH
Dec 4, 2025, 23:31
Caterina Casari – The New Research Director at the HITh Lab Inserm U1176
Caterina Casari, Researcher (CRCN) at Inserm, shared on LinkedIn:
”I am very happy to share that I’m starting a new position as Research Director (DR2) at the HITh lab Inserm U1176 – INSERM
My heartfelt thanks go to Cécile Denis, Peter Lenting and Olivier Christophe who welcomed me into their group 15 years ago and have been by my side ever since.
So many mentors, colleagues, students and friends have supported and inspired me along the way – I’m grateful to each and every one of you.”
More winner stories featured in Hemostasis Today.
-
Sep 9, 2026, 07:31Fateema Capery: The State of Hemophilia Care in Mauritius and What Comes Next
-
Sep 9, 2026, 07:11Building a Stronger Future for Hemophilia Care in Bangladesh – World Federation of Hemophilia
-
Sep 9, 2026, 07:05Nael Ismail: Gene and Cell Therapy Are Transforming the Treatment of Human Genetic Diseases
-
Sep 9, 2026, 06:59Suswapna Singh Rawat: The Role of Platelets in Heart Disease and Antiplatelet Therapy
-
Sep 9, 2026, 06:39Chaza Alaji: How Hemophilia Became a Disease of Precision Medicine
-
Sep 9, 2026, 05:52Faheema Hasan: New ASH 2026 Guidelines Redefine Initial and Second-Line ITP Therapy
-
Sep 9, 2026, 05:43Thomas Pincez: Clonal Hematopoiesis Linked to Increased Risk of Autoimmune Hemolytic Anemia
-
Sep 9, 2026, 05:33Marianne Yee: Sickle Cell Disease and the Human Side of Medical Research
-
Sep 8, 2026, 16:14Heghine Khachatryan: Colombo 2026 Insights on Point-of-Care Ultrasound in Hemophilia Joint Care